This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
foafhttp://xmlns.com/foaf/0.1/
n5http://linked.opendata.cz/resource/drugbank/mixture/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08988/identifier/wikipedia/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08988/identifier/kegg-drug/
n14http://www.drugs.com/international/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08988/identifier/drugbank/

Statements

Subject Item
n2:DB08988
rdf:type
n3:Drug
n3:description
Ethoheptazine (trade name Zactane) is an opioid analgesic from the phenazepine family. It was invented in the 1950s and is related to other drugs such as proheptazine. Ethoheptazine is no longer marketed in the United States.
n3:group
withdrawn
owl:sameAs
n12:DB08988
dcterms:title
Ethoheptazine
adms:identifier
n8:DB08988 n9:D01435 n10:Ethoheptazine
n3:synonym
Ethoheptazine Etoheptazina Ethoheptazinum Ethoheptazin
n3:mixture
n5:271B6273-363D-11E5-9242-09173F13E4C5
n3:salt
n3:synthesisReference
U.S. Patent 2,666,050.
foaf:page
n14:ethoheptazine.html
n3:IUPAC-Name
n4:271B6278-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B627E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B627D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B627A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B627B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B627C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6276-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6277-363D-11E5-9242-09173F13E4C5 n4:271B6274-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6275-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B6284-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6285-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B627F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B6280-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B6282-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B6281-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B6283-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
77-15-6
n3:Bioavailability
n4:271B6289-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B628B-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B628C-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B628D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6288-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6287-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B628A-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6279-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6286-363D-11E5-9242-09173F13E4C5